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Increased Expression of Mineralocorticoid Receptor
in Human Atrial Fibrillation and a
Cellular Model of Atrial Fibrillation
Chia-Ti Tsai, MD, PHD,* Fu-Tien Chiang, MD, PHD,*† Chuen-Den Tseng, MD, PHD,*
Juey-Jen Hwang, MD, PHD,* Kuan-Ting Kuo, MD,*‡ Cho-Kai Wu, MD,* Chih-Chieh Yu, MD,*
Yi-Chih Wang, MD,* Ling-Ping Lai, MD, PHD,*§ Jiunn-Lee Lin, MD, PHD*
Taipei, Taiwan
Objectives This study was designed to evaluate the status of steroidogenesis proteins and de novo synthesis of aldosterone
in the atrium, and relationships of these factors to atrial fibrillation (AF).
Background The role of mineralocorticoid in the pathogenesis of AF is unknown.
Methods We studied atrial expression of steroidogenesis proteins and aldosterone level in patients with and without AF,
and in HL-1 atrial myocytes. We also investigated the electrophysiologic effects and signal transduction of aldo-
sterone on atrial myocytes.
Results We found basal expressions of mineralocorticoid receptors (MRs), glucocorticoid receptors, and 11-beta-
hydroxysteroid dehydrogenase type 2 (11bHSD2) but not 11-beta-hydroxylase (CYP11B1) or aldosterone syn-
thase (CYP11B2) in human atria and HL-1 myocytes. There was no significant difference of mean atrial aldoste-
rone level between patients with AF and those with normal sinus rhythm. However, patients with AF had a
significantly higher atrial MR expression compared with those with normal sinus rhythm (1.73  0.24-fold,
p  0.001). Using mouse HL-1 atrial myocytes as a cellular AF model, we found that rapid depolarization in-
creased MR expression (1.97  0.72-fold, p  0.008) through a calcium-dependent mechanism, thus augment-
ing the genomic effect of aldosterone signaling as evaluated by MR reporter. Aldosterone increased intracellular
oxidative stress through a nongenomic pathway, which was attenuated by nicotinamide adenine dinucleotide
phosphate oxidase inhibitor diphenyleneiodonium, but not by MR-blockade spironolactone. Aldosterone in-
creased expression of the alpha-1G and -1H subunits of the T-type calcium channel and thus increased the
T-type calcium current (–13.6  2.9 pA/pF vs. –4.5  1.6 pA/pF, p  0.01) and the intracellular calcium load
through a genomic pathway, which were attenuated by spironolactone, but not by diphenyleneiodonium.
Conclusions Expression of MR increased in AF, thus augmenting the genomic effects of aldosterone. Aldosterone induced
atrial ionic remodeling and calcium overload through a genomic pathway, which was attenuated by spironolac-
tone. These results suggest that aldosterone may play a role in AF electrical remodeling and provide insight into
the treatment of AF with MR blockade. (J Am Coll Cardiol 2010;55:758–70) © 2010 by the American College
of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.09.045w
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ahe renin-angiotensin system (RAS) is involved in many
ardiovascular diseases. Recent reports suggest that atrial
brillation (AF) is associated with activation or up-
egulation of RAS in the atria in humans (1) and in animal
odels of AF (2). Aldosterone, a mineralocorticoid, is a
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he National Taiwan University Hospital (94A03 and 96M27), the National Science
ouncil (95-2314-B-002-087-MY3, 96-2314-B-002-187-MY3, and 98-2314-B-
02-134-MY3), and the New Century Health Care Promotion Foundation.r
Manuscript received June 14, 2009; revised manuscript received September 1, 2009,
ccepted September 7, 2009.ell-known component of the RAS, but its role in AF has
ot been investigated in detail. It has been shown that
ldosterone levels are elevated in patients with persistent
F, and restoration of sinus rhythm with electrical cardio-
ersion lowers serum aldosterone concentrations (3).
See page 771
Aldosterone is a biologic steroid. Aldosterone synthase
elongs to the cytochrome P450 (CYP) family and is also
alled CYP11B2. It is the key enzyme for synthesizing
ldosterone. Synthesis of the glucocorticoids, corticoste-
one, and cortisol requires a distinct isoenzyme closely
r
1
c
r
1
t
c
o
t
c
fi
c
s
a
a
1
c
a
e
a
a
s
M
S
H
w
w
f
s
e
H
(
m
O
t
s
T
T
r
(
f
M
c
m
E
p
a
b
w
o
p
f
m
t
C
m
M
c
r
m
b
(
n
w
p
c
l
f
s
S
p
w
d
s
a
m
h
r
A
s
R
M
i
s
t
v
v
l
p
(
v

h
a
e
p
(
2
i
w
(
n
w
N
759JACC Vol. 55, No. 8, 2010 Tsai et al.
February 23, 2010:758–70 Mineralocorticoid Receptor and AFelated to aldosterone synthase; this isoenzyme is called
1-beta-hydroxylase, or CYP11B1. Mineralocorticoid re-
eptor (MR) is the nuclear receptor of aldosterone and is
esponsible for the genomic effects of aldosterone. The enzyme
1-beta-hydroxysteroid dehydrogenase type 2 (11bHSD2)
ightly regulates MR binding and selectively metabolizes glu-
ocorticoids to inactive metabolites, allowing aldosterone to
ccupy and activate the MR.
De novo cardiac synthesis of aldosterone by CYP11B2 in
he ventricular myocardium is reported and has been impli-
ated in the pathogenesis of ventricular hypertrophy and
brosis (4). Unknown issues are whether proteins related to
ardiac steroidogenesis are expressed, whether de novo
ynthesis of aldosterone occurs in the atrial myocardium,
nd whether expression of these proteins was altered in AF.
The aims of this study were 3-fold. First, we wanted to
ssess the expression of MRs, glucocorticoid receptors (GRs),
1bHSD2, CYP11B1, and CYP11B, as well as de novo
ardiac synthesis of aldosterone in human atria and murine
trial HL-1 myocytes. Second, we determined whether
xpression of these proteins was altered in human AF and in
cellular model of AF. Third, we investigated the effect of
ldosterone on HL-1 atrial myocytes and the possible
ignaling pathways.
ethods
ee the Online Appendix for an expanded Methods section.
uman atrial tissues. Samples of right atrial appendages
ere obtained from consecutive patients with or without AF
ho were undergoing mitral and/or aortic valve replacement
or significant valvular disease. Another study group without
ignificant valvular heart disease, who had less left atrial
nlargement, was also included.
L-1 cell culture and rapid electrical-field stimulation
RES). The HL-1 atrial cell line was derived from adult
ouse atria obtained from Louisiana State University, New
rleans, and cultured as previously described (5–7). RES of
he cultured HL-1 cells was performed as previously de-
cribed (6).
ransient transfection and MR reporter luciferase assay.
ransient transfection of HL-1 cells with MR luciferase
eporter was accomplished by using Lipofectamine 2000
Invitrogen, Carlsbad, California) according to the manu-
acturer’s instructions as previously described (5,7).
easurement of myocardial aldosterone levels. The con-
entration of tissue aldosterone was measured by radioim-
unoassay as previously described (8).
xtraction of ribonucleic acid and reverse transcription-
olymerase chain reaction (RT-PCR). The extraction
nd quantification of messenger ribonucleic acid (mRNA)
y means of reverse transcription-polymerase chain reaction
ere performed as previously described (6,7,9). The mRNA
f cells of human adrenocortical cell line H295R (kindly
rovided by Dr. K. D. Wu) was used as the positive control
or human CYP11B1 and CYP11B2. The mRNA from the 0ouse adrenal gland was used as
he positive control for mouse
YP11B1 and CYP11B2 (HL-1
yocytes).
easurement of transmembrane
urrents and sarcoplasmic
eticulum calcium load. Trans-
embrane currents were measured
y using a patch-clamp amplifier
8900, Dagan Corporation, Min-
eapolis, Minnesota) by applying a
hole-cell recording technique as
reviously described (7). The sar-
oplasmic reticulum (SR) calcium
oad was measured by rapid caf-
eine application as previously de-
cribed (7).
tatistical analysis. Data are
resented as mean  SD and
ere analyzed by using the Stu-
ent t test for 2-group compari-
ons, and 1-way analysis of vari-
nce for comparisons among
ore than 2 groups, with post
oc Student t tests with Bonfer-
oni corrections for the p values.
p value 0.05 indicated a
tatistically significant difference.
esults
yocardial aldosterone levels
n the human atrium. Table 1
hows the clinical characteristics of
he study subjects with significant
alvular heart disease undergoing
alve replacement surgery. Mean
eft atrial dimension was larger in
atients with AF than in subjects with normal sinus rhythm
NSR). We detected no significant difference in other clinical
ariables between these groups. The mean AF duration was 8.3
5.6 (0.6 to 19.4) years for the patients with AF. The mean
eart rate for the patients with AF was 77.3  9.3 beats/min
nd 71.1  6.3 beats/min for those with NSR (p  0.053).
Histologically, we found a nonsignificant increase of
xtracellular matrix accumulation and a trend of increase of
rocollagen expression (COL1A1) in subjects with AF
extracellular matrix: 16.3  4.4 % in subjects with NSR vs.
0.7 5.3% in those with AF, p 0.157; 1.28 0.22-fold
ncrease of COL1A1 expression in subjects of AF compared
ith those with NSR, p  0.066, n  6 for each group)
Online Fig. 1). Mean aldosterone levels in atrial tissues did
ot significantly differ between subjects with AF and those
ith NSR (6.12  1.73 pg/mg protein in subjects with
SR vs. 5.83  1.54 pg/mg protein in those with AF, p 
Abbreviations
and Acronyms
11bHSD2  11-beta-
hydroxysteroid
dehydrogenase type 2
AF  atrial fibrillation
BAPTA-AM  1,2-bis
(aminophenoxy) ethane-
N,N,N=,N=-tetraacetic acid
acetomethyl ester
COL  procollagen type
CYP  cytochrome P450
GR  glucocorticoid
receptor
ICaL  L-type calcium
current
ICaT  T-type calcium
current
IKr  rapidly activating
delayed rectifier potassium
current
MR  mineralocorticoid
receptor
mRNA  messenger
ribonucleic acid
NSR  normal sinus rhythm
RAS  renin-angiotensin
system
RES  rapid electrical-field
stimulation
ROS  reactive oxygen
species
RT-PCR  reverse
transcription–polymerase
chain reaction
SR  sarcoplasmic
reticulum.643, n  14 for each group) (Fig. 1).
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Mineralocorticoid Receptor and AF February 23, 2010:758–70Mean aldosterone levels in atrial tissues also did not
ignificantly differ between subjects with AF and those with
SR in the second study group without significant valvular
eart disease (Online Appendix).
asal expression of MRs, GRs, 11bHSD2, CYP11B1,
nd CYP11B2 in human atrium and murine atrial HL-1
ells. Levels of expression for CYP11B1 and CYP11B2
ere high in the human adrenocortical cell line (Fig. 2A).
e observed basal expression of MRs, GRs, and 11b-
SD2 but not CYP11B1 and CYP11B2 in the human atria
Fig. 2A).
In HL-1 cells, expression patterns for MR, GRs, 11b-
SD2, CYP11B1, and CYP11B2 were similar to those
een in the human atrium (Fig. 2B); again, expression of
YP11B1 and CYP11B2 was absent. Although some have
eported that angiotensin II can induce CYP11B2 expres-
ion (10), we found no induction of CYP11B2 expression in
L-1 myocytes after stimulation with angiotensin II
atient CharacteristicsTable 1 Patient Characteristics
Age, yrs Sex VHD
SR (n  14)
73 F AR
66 M MR
54 M MR
83 F AR, MR
59 M MR
67 M AR, MR
52 F MR
43 M AR
55 M MR
72 F AR
54 M MR
65 F AR, TR
77 M MR
72 F MR, TR
Total 63.7 11.2 8 M/6 F
AF (n  14)
69 M AR
63 F MR
70 M AR
65 M MR
64 F AR, MR
73 M MR
58 M MR
71 M MR, TR
73 M MR, TR
43 M MR
73 F MR
79 F MR
59 M AR
80 F MR, AR
Total 67.1 9.6 9 M/5 F
p  0.05 versus sinus rhythm.
A  angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker; AF  chronic p
 digoxin; Di  diuretics; DM  diabetes mellitus; HTN  hypertension; LAD  left atrial dimen
R  sinus rhythm; TR  tricuspid regurgitation; VHD  valvular heart disease requiring valve repmol/l for as long as 24 h (data not shown). increased expression of MRs in human AF. When we
ompared expression levels for MRs, GRs, and 11b-HSD2
etween patients with AF and those with NSR, we found
hat expression of MR (Fig. 3C) was higher in the AF group
han in the other group (1.73  0.24-fold, p  0.001 by
uantitative RT-PCR, n  14 for each group). Mean
xpression levels of GRs (Fig. 3B) and 11b-HSD2 (Fig. 3A)
id not notably differ.
The results were similar in the second study group without
ignificant valvular heart disease (Online Fig. 2).
apid depolarization increased sustained elevation of
ntracellular calcium, and increased MR expression and
ldosterone responsiveness in HL-1 myocytes. In conflu-
nt HL-1 cells, we noted rhythmic oscillation of the
uorescence signal (6). Under RES at 1.0 V/cm and 10 Hz,
levation of the fluorescence signal with fibrillatory-like
orphology was observed (6). This finding indicated sus-
ained elevation of intracellular calcium levels, a character-
DM LVEF, % LAD, mm Drugs
0 56 43 C, Di
1 62 42 O, Di, D
0 63 48 D, Di
0 51 55 Di, D
0 36 47 A, Di, D
1 49 42 O, D
0 57 53 A, D
0 82 46 Di
1 50 54 A, Di, D, O
1 56 48 C, Di, D, O
1 65 41 D, O
0 45 49 Di, D
0 71 45 C, Di
0 53 54 Di, D
56.8 11.4 47.6 4.8
0 64 54 Di, D
0 57 53 Di, D
0 47 57 C, Di, D
1 43 48 C, Di, O
0 33 49 A, B, Di, D
0 56 54 Di, D
0 53 55 C, D
0 73 57 C, Di, D
0 67 65 B, Di, D
0 51 53 Di, D
0 55 46 Di, D
0 61 52 A, D
0 63 44 C, Di
0 60 58 Di, D
55.9 10.3 53.2 5.4*
nt atrial fibrillation; AR  aortic regurgitation; B  beta-blocker; C  calcium-channel blockers;
VEF  left ventricular ejection fraction; MR  mitral regurgitation; O  oral hypoglycemic agent;
nt.HTN
1
0
0
0
1
0
1
0
0
1
0
0
0
0
0
0
1
0
0
1
1
0
0
0
0
1
0
0
ersistestic feature of atrial myocytes during AF.
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February 23, 2010:758–70 Mineralocorticoid Receptor and AFFigure 4 shows changes in the expression of MRs, GRs,
nd 11bHSD2 under RES. Expression of MR was up-
egulated in a time-dependent manner (1.97  0.72-fold
fter 24 h of stimulation, p  0.008) (Fig. 4A). This effect
as abolished by intracellular calcium chelator 1,2-bis (amino-
henoxy) ethane-N,N,N=,N=-tetraacetic acid acetomethyl
ster (BAPTA-AM) (10 mol/l) and the L-type calcium-
hannel blocker verapamil (10 mol/l) (Fig. 4B), which indi-
ated that it was calcium-dependent. Expressions of GR and
1bHSD2 were down-regulated, but the change was not sta-
istically significant (Fig. 4A). There was no detectable aldo-
terone in the serum-free culture medium, either before or after
ES. The up-regulation of MR by RES was also not atten-
ated by the MR-blockade spironolactone (Online Fig. 3).
It has been shown that calcium overload during rapid pacing
nduces oxidative stress via nicotinamide adenine dinucleotide
hosphate oxidase (11). Therefore, it is possible that the
p-regulation of MR by RES is both calcium- and oxidative
tress–dependent. However, we found that RES-induced MR
xpression was not attenuated by nicotinamide adenine dinu-
leotide phosphate oxidase inhibitor diphenyleneiodonium or
he reactive oxygen species (ROS) scavenger N-acetylcysteine
Online Fig. 4).
We also performed studies to prove that the effect of
ES on MR expression was not due to the nonspecific effect
f electrolysis or electrical current produced in the medium
y RES. See the results in the Online Appendix (Online
ig. 5).
To study the functional importance of increased MR ex-
ression, we performed MR reporter luciferase assay. When
L-1 myocytes were subjected to aldosterone stimulation (0.1
mol/l for 24 h), MR reporter luciferase activity increased
.7-fold, which was attenuated by the MR-competitive antag-
nist spironolactone (1 mol/l) (Fig. 4C, open bars). This
esult suggested the specificity of the MR reporter to aldoste-
Figure 1 Mean Atrial Tissue Aldosterone Level
in Patients With NSR and Those With AF
No significant difference of mean atrial tissue aldosterone level between
patients with normal sinus rhythm (NSR) and those with atrial fibrillation (AF).
Atrial tissue aldosterone level was measured by radioimmunoassay. Data rep-
resent mean  SD and n  14 for each group.one stimulation. When HL-1 myocytes were subjected toimultaneous aldosterone and RES stimulations, MR reporter
uciferase activity increased 2.4-fold, which was also attenuated
y the MR-competitive antagonist spironolactone (1 mol/l)
Fig. 4C, solid bars). The increase of luciferase activity in
esponse to aldosterone stimulation was higher in the presence
han in the absence of RES (2.4  0.5-fold with RES vs.
.7  0.3-fold without RES; p  0.015), suggesting the
unctional importance of increased MR expression due to
ES. The effect of RES to increase aldosterone responsive-
ess was also attenuated by intracellular calcium chelator
APTA-AM (10 mol/l) and the L-type calcium-channel
locker verapamil (10 mol/l) (Online Fig. 6).
lectrophysiological effects of aldosterone on atrial
yocytes. HL-1 myocytes had typical L- and T-type
alcium currents (ICaL and ICaT), which were sensitive to
Figure 2 Basal Expressions of Steroidogenesis Proteins in
the Human Atrium and the Mouse HL-1 Atrial Myocytes
Basal expressions of 11-beta-hydroxylase (CYP11B1), aldosterone synthase
(CYP11B2), mineralocorticoid receptor (MR), glucocorticoid receptor (GR), and
11-beta-hydroxysteroid dehydrogenase type 2 (11bHSD2) in the human atrium
and the mouse atrial HL-1 myocytes. There are no expressions of CYP11B1
and CYP11B2 in the human atrium and the mouse HL-1 atrial myocytes. Total
ribonucleic acid was isolated and reverse transcription-polymerase chain reac-
tion products with specific primer pairs were visualized by electrophoresis.
(A) The left panel shows the polymerase chain reaction results of a sample
from right atrial appendage of 1 patient, and the right panel shows those of a
positive control for human CYP11B1 and CYP11B2 from human adrenocortical
H295R cells. (B) The left panel shows the polymerase chain reaction results of
HL-1 atrial myocytes, and the right panel shows those of a positive control for
mouse CYP11B1 and CYP11B2 from the mouse adrenal gland. bp  base pair;
CYI  CYP11B1; CYII  CYP11B2; GP  glyceraldehyde 3-phosphate dehydroge-
nase; HII 11bHSD2; MW  molecular weight maker.
n
A
d
a
c
I
b
i
a
l
t
A
d
t
6
c
C
f
(
v
762 Tsai et al. JACC Vol. 55, No. 8, 2010
Mineralocorticoid Receptor and AF February 23, 2010:758–70ifedipine 3 mol/l and nickel 1 mol/l, respectively (7).
ldosterone (0.1 mol/l for 24 h) increased ICaT current
ensity (peak inward current: –13.6  2.9 pA/pF for
ldosterone treatment [n  6] and –4.5  1.6 pA/pF for
ontrol [n  6]; p  0.01), without a significant change in
CaL (Figs. 5A and 5B). Coadministration of MR-
lockade attenuated the increase in ICaT density (peak
nward current: –6.7  1.8 pA/pF [n  6]; p  0.01 vs.
ldosterone treatment) (Figs. 5A and 5B).
HL-1 myocytes also had typical rapidly-activating de-
Figure 3 Increased Expression of MR in Patients With AF
Increased expression of the messenger ribonucleic acid (mRNA) level of MR witho
(11bHSD2) in patients with atrial fibrillation (AF). Total ribonucleic acid was isolate
trophoresis. Both semiquantitative and quantitative reverse transcription-polymera
ized to that of glyceraldehyde 3-phosphate dehydrogenase (GAPDH). (A to D) The
MR (C), and GAPDH (D) in patients with AF and those with normal sinus rhythm (N
with AF and those with NSR. Data were normalized to GADPH level (D), and repres
Abbreviations as in Figure 2.ayed rectifier potassium currents (IKrs), which were sensi- sive to the specific IKr blocker E4031 (1 mol/l) (Fig. 6A).
ldosterone (0.1 mol/l for 24 h) decreased IKr current
ensity (peak tail current: 7.9  4.6 pA/pF for aldosterone
reatment [n  6] and 18.2  3.7 pA/pF for control [n 
]; p 0.01) (Figs. 6B and 6C). We observed no significant
hanges in other potassium currents (data not shown).
oadministration of MR-blockade spironolactone (1 mol/l
or 24 h) also attenuated the decrease in IKr current density
peak outward current: 15.5  2.6 pA/pF [n  6]; p  0.01
s. aldosterone treatment) (Figs. 6B and 6C). It has been
ificant changes of those of GR and 11-beta-hydroxysteroid dehydrogenase type 2
reverse transcription-polymerase chain reaction products were visualized by elec-
in reaction were used to quantify mRNA levels of MR, GR, and 11bHSD2 normal-
e transcription-polymerase chain reaction results of the 11bHSD2 (A), GR (B),
E) The mean expression level of mRNA of 11bHSD2, GR, and MR in patients
ean  SD (n  14 for each group). **p  0.01 versus patients with NSR.ut sign
d and
se cha
revers
SR). (
ent mhown that spironolactone also exerts MR-independent effects
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February 23, 2010:758–70 Mineralocorticoid Receptor and AFFigure 4 REF Stimulation Increases MR Expression and Aldosterone Responsiveness in HL-1 Atrial Myocytes
Rapid electrical-field stimulation (RES) increases MR expression and aldosterone responsiveness in HL-1 atrial myocytes. (A) Total ribonucleic acid (RNA) was isolated from HL-1
myocytes left untreated (0 h) or treated for indicated times with RES. Reverse transcription-polymerase chain reaction products were visualized by electrophoresis. The messen-
ger RNA levels of MR, GR, and 11-beta-hydroxysteroid dehydrogenase type 2 (11bHSD2) were quantified and normalized to that of glyceraldehyde 3-phosphate dehydrogenase
(GAPDH). (B) Total RNA was isolated from HL-1 myocytes left untreated (0 h) or treated for indicated times with RES  1,2-bis (aminophenoxy) ethane-N,N,N=,N=-tetraacetic acid
(10 mol/l) and RES  verapamil (10 mol/l). The mRNA levels of MR were quantified and normalized to that of GAPDH. (C) HL-1 atrial myocytes were transiently transfected
with MR luciferase reporter and the plasmid of renilla luciferase-thymidine kinase (pRL-TK) vector for an internal control, then subjected to RES alone, RES plus aldosterone (Ald)
(0.1 mol/l) simultaneously, RES  aldosterone (0.1 mol/l) plus spironolactone (Spir) (1 mol/l), and RES plus spironolactone (1 mol/l) for 24 h, and then luciferase activi-
ties were measured (solid bars). Another set of myocytes with the same treatment but without RES were used for comparison (open bars). Data represent mean  SD of
3 independent experiments for reverse transcription–polymerase chain reaction study and 6 for luciferase study. *p  0.05 and **p  0.01 versus control; #p  0.05 and
##p  0.01 versus aldosterone-treated cells. CTL  control patients; other abbreviations as in Figure 2.
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Mineralocorticoid Receptor and AF February 23, 2010:758–70locking IKr potassium channels (12). We found that single
pironolactone did not exert any effect on the current density of
Kr in HL-1 atrial myocytes (Figs. 6B and 6C).
Aldosterone increased mRNA levels of the alpha-1G and
1H subunits of ICaT and decreased that of the ether-a-go-
o-related (ERG) subunit of IKr (Figs. 7A and 7B). Co-
dministration of MR-blockade attenuated these effects (Figs.
C and 7D). We noted no significant changes in the mRNA
evels of channel subunits of other ionic channels, such as
lpha-1C, SCN5A, KVLQT1, Kv4.2, Kir2.1, Kv 2.1, HCN1,
Figure 5 Aldosterone Increases ICaT in HL-1 Atrial Myocytes
Aldosterone increases T-type inward calcium current (ICaT) in HL-1 atrial myocytes
inward calcium currents are shown for the control cells, aldosterone-treated (0.1 
24 h)-treated cells. Total calcium currents including L-type (ICaL) and ICaT were ob
–80 mV. The ICaL current was obtained by a family of depolarization steps to 70
ing total calcium current by ICaL. (Inset) Voltage protocol. (B) Representative curr
and aldosterone plus spironolactone-treated cells (all n  6).nd HCN2 (data not shown), after aldosterone stimulation. tAldosterone also increased SR calcium load of HL-1
trial myocytes (Fig. 8). Coadministration of MR-blockade
pironolactone (1 mol/l for 24 h) attenuated this change.
xidative stress and aldosterone effects on atrial myo-
ytes. The aldosterone signaling mechanisms are very com-
lex, including genomic and nongenomic effects. It has been
hown that aldosterone promotes oxidative stress through
he nongenomic effect and is MR-independent (13). On the
ther hand, other studies have also shown that MR antag-
nists reduce oxidative stress (14). Therefore, we evaluated
is attenuated by spironolactone. (A) Representative recordings of whole-cell
, 24 h) and aldosterone (0.1 mol/l, 24 h) plus spironolactone (1 mol/l,
by a family of depolarization steps to 60 mV from the holding potential
rom the holding potential –50 mV. The ICaT current was obtained after subtract-
nsity-voltage relationships of ICaL and ICaT in control cells, aldosterone-treated,, which
mol/l
tained
mV f
ent dehe role of oxidative stress and the relative influence of
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February 23, 2010:758–70 Mineralocorticoid Receptor and AFenomic and nongenomic mechanisms to mediate aldoste-
one effect on ionic remodeling.
We found that aldosterone time-dependently increased
ntracellular level of ROS, as evaluated by lucigenin-
ependent chemiluminescence (7) (Online Fig. 7A). This
ffect was nongenomic, because it was not attenuated by the
lassical MR-blockade spironolactone. It was nicotinamide
denine dinucleotide phosphate oxidase-dependent, because it
as attenuated by nicotinamide adenine dinucleotide phos-
hate oxidase inhibitor diphenyleneiodonium and the ROS
Figure 6 Aldosterone Decreases IKr in HL-1 Atrial Myocytes
Aldosterone decreases rapidly-activating delayed rectifier potassium current (IKr) in
a family of depolarization steps from –80 mV, and was measured as the tail curre
(B) Representative recordings of IKr tail currents are shown for the control cells, a
tone (1 mol/l, 24 h)-treated, and spironolactone-treated (1 mol/l, 24 h) cells. (
cells (n  6), aldosterone-treated (n  6), aldosterone plus spironolactone-treatedcavenger N-acetylcysteine (Online Fig. 7B). dTherefore, it is possible that the effect of aldosterone on
onic channel expression may be through this ROS-
ependent nongenomic effect. However, we found that the
ffect of aldosterone to modulate ionic channel gene expres-
ions was not attenuated by N-acetylcysteine and diphenyle-
eiodonium (Online Fig. 8). As shown before, the effect of
ldosterone to modulate ionic channel gene expressions was
ttenuated by MR-blockade. Taken together, aldosterone
riggers electrical remodeling through the classical genomic,
R-dependent pathway, but not the nongenomic, ROS-
atrial myocytes, which is attenuated by spironolactone. (A) IKr was obtained by
the repolarization step to –40 mV, which was sensitive to E4031 (1 mol/l).
rone-treated (0.1 mol/l, 24 h), aldosterone (0.1 mol/l, 24 h) plus spironolac-
resentative current density-voltage relationships of IKr tail currents in control
6), and spironolactone-treated (n  6) cells.HL-1
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ain findings. We first demonstrated that in patients with
F, atrial tissue MR expression was increased, although atrial
issue aldosterone levels were not altered. In the in vitro cellular
odel of AF, MR expression increased with rapid depolariza-
ion. We observed a concomitantly increased response to aldo-
terone stimulation, which was attenuated by MR-blockade.
ldosterone increased the inward T-type calcium current and
R calcium load. These changes suggest the potential role of
Figure 7 Aldosterone Modulates Expressions of Ionic Channel
Aldosterone increases expressions of the alpha-1G and -1H subunits of the T-type
of the rapidly-activating delayed rectifier potassium channel in HL-1 atrial myocytes
isolated from HL-1 myocytes left untreated (control subjects) or treated for indicat
tion products were visualized by electrophoresis. (B) The messenger RNA levels o
of glyceraldehyde 3-phosphate dehydrogenase (GAPDH). (C) Total RNA was isolate
with aldosterone (0.1 mol/l) plus spironolactone (1 mol/l). Reverse transcriptio
senger RNA levels of alpha-1G, -1H, and ERG subunit proteins were quantified and
ments. *p  0.05 versus control; **p  0.01 versus control. Abbreviations as inn augmented aldosterone-MR effect in calcium overload auring AF. Blockage of this effect with MR-blockade may be
n option to prevent calcium overload and treat AF.
xpression of steroidogenesis proteins in the human atrium.
o our knowledge, basal expression of the proteins of steroido-
enesis in the human atrium and its relationship to AF has not
een reported in the literature. Expression of CYP11B1 and
YP11B2 has been reported in failing or hypertrophic myo-
ardium in humans but not in normal hearts (15). We found
lmost no basal expression of CYP11B1 or CYP11B2 in the
s in HL-1 Atrial Myocytes
m channel and decreases expression of the ether-a-go-go-related (ERG) subunit
f which are attenuated by spironolactone. (A) Total ribonucleic acid (RNA) was
es with aldosterone (0.1 mol/l). Reverse transcription-polymerase chain reac-
-1C, -1G, -1H, and ERG subunit proteins were quantified and normalized to that
HL-1 myocytes left untreated (control subjects) or treated for indicated times
erase chain reaction products were visualized by electrophoresis. (D) The mes-
alized to that of GAPDH. Data represent mean  SD of 3 independent experi-
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Figuretrial tissue of patients with either AF or normal sinus rhythm.
T
p
u
d
c
o
s
v
i
l
c
M
s
r
e
l
t
l
w
W
i
l
e
i
g
i
m
r
a
i
c
d
f
i
c
c
a
m
o
d
e
e
i
A
A
767JACC Vol. 55, No. 8, 2010 Tsai et al.
February 23, 2010:758–70 Mineralocorticoid Receptor and AFhe aldosterone in the atrial tissue, as detected in our study,
robably came from the systemic circulation (16).
Expression of MRs, GRs, and 11bHSD2 may be ubiq-
itous and were detectable in the human atrium, as we
emonstrated. We further found that MR expression in-
reased in the atrial tissue from patients with AF, which, to
ur knowledge, has not been reported in the literature. The
tatus of MR expression has been investigated in the left
entricles of rats with myocardial infarction, but no signif-
cant change was found when compared with those from the
eft ventricles of normal rats (17).
Because the aldosterone detected in the atrial tissue
omes from the systemic circulation, the abundance of atrial
R expression is the major factor determining the effect of
erum aldosterone on the atrial tissue. MRs are the nuclear
eceptors for aldosterone and are responsible for its genomic
ffects. In the cellular model, we showed that rapid depo-
arization increased MR expression, which was similar to
he findings in the human atrial samples. Using a promoter
uciferase assay, we verified that increased MR expression
as associated with increased aldosterone responsiveness.
e also found that the effects of aldosterone, including
ncreased ICaT, decreased IKr and increased SR calcium
oad on atrial myocytes, were mediated through the genomic
Figure 8 Aldosterone Increases the SR Calcium Load in HL-1 A
Aldosterone increases the sarcoplasmic reticulum (SR) calcium load in HL-1 atrial
sured by rapid caffeine application (50 mmol/l) and was reported as F1/F0. Arrow
fluorescence level (peak F1/F0) after rapid caffeine application in the control cells
(AldSpir) cells (n  6). *p  0.05 versus control; #p  0.05 versus aldosteroneffect, which were attenuated by the classical MR compet- otive antagonist spironolactone, but not through the non-
enomic oxidative pathway (13).
The exact mechanism by which AF or rapid depolarization
ncreases MR expression is interesting. In our cellular AF
odel, intracellular calcium concentration was elevated by
apid depolarization (6). This result is similar to that found in
rapid-pacing model of AF (18). We also showed that
ntracellular calcium chelator BAPTA-AM and the L-type
alcium-channel blocker verapamil abolished rapid
epolarization-induced increment of MR expression. There-
ore, the mechanism may be calcium-dependent. Increased
ntracellular calcium due to rapid depolarization may trigger
alcium-related signaling pathways (such as calcium-/
almodulin-dependent protein kinase or nuclear factor of
ctivated T-cell pathway) and increases MR expression by
eans of a transcriptional mechanism. Although calcium
verload and oxidative stress are interrelated processes (11), we
id not demonstrate that rapid depolarization-induced MR
xpression through the oxidative stress pathway.
The proposed signaling pathway of AF-induced MR
xpression and the signaling pathway of aldosterone-
nduced ionic remodeling are illustrated in Figure 9.
ldosterone, electrical remodeling, and mechanism of AF.
s mentioned earlier, rapid depolarization-induced calcium
Myocytes
tes, which is attenuated by spironolactone. (A) The SR calcium load was mea-
cate caffeine application. (B) The bar graph shows the average peak normalized
aldosterone-treated (Ald), and aldosterone plus spironolactone-treated
d cells.trial
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(CTL),
-treateverload triggers the observed increase in MR gene expres-
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Mineralocorticoid Receptor and AF February 23, 2010:758–70ion and aldosterone responsiveness. This finding suggests
hat calcium influences aldosterone effects. However, we
lso showed that aldosterone increases ICaT and induces
alcium overload. These results indicate a positive feedback
icious cycle (Fig. 9), which may contribute to the mecha-
ism of calcium overload and electrical remodeling in AF
18,19). This is in accordance with the recent report that
elective ICaT blocker mibefradil successfully prevents
achycardia-induced electrical remodeling (20). However,
his drug is currently not available in the market due to its
evere hepatic toxicity. In this regard, MR-blockade may be
he potential available drug to prevent tachycardia-induced
alcium overload and electrical remodeling.
ldosterone, structural remodeling, and mechanism of AF.
ecently it has been demonstrated that CYP11B2 T-344C
romoter polymorphism, which is associated with a higher
Figure 9 A Summary Figure Demonstrating the Regulation of S
A summary figure demonstrates the signaling cascades of increased mineraloc
induced change of ionic channel gene expression. Figure illustration by Rob Fle
cium release; DPI  diphenyleneiodonium; EC  excitation-contraction; NAC 
nuclear factor of activated T-cells; ROS  reactive oxygen species; RYR  ryan
phatase 2; other abbreviations as in Figures 1, 3, 4, and 8.ldosterone level, was an independent predictor of AF in natients with heart failure (21). The prominent type of atrial
emodeling in the presence of structural heart disease or heart
ailure is the structural remodeling. Therefore, aldosterone may
lay a role in the mechanism of atrial structural remodeling.
he second part of the present study focuses on a cellular
odel of AF examining the effects of rapid depolarization.
his is not a model of structural remodeling, because rapid
epolarization or atrial tachycardia causes mainly electrical
emodeling. Furthermore, the patients in the first part of the
tudy had significant structural heart disease as reflected by an
ncreased left atrial dimension, especially the group with
ignificant valvular heart disease.
However, rapid depolarization per se could also induce
tructural remodeling (6). Our previous study showed that
apid depolarization of atrial myocytes during AF induced a
aracrine secretion of angiotensin II, which may stimulate the
ing Cascades Proposed in the Present Study
id receptor (MR) expression by rapid-depolarization and those of aldosterone-
Ca  calcium; Ca/CaM  calcium/calmodulin; CICR  calcium-induced cal-
tylcysteine; NADPH  nicotinamide adenine dinucleotide phosphate; NFAT 
receptor; SERCA2  sarcoplasmic reticulum calcium adenosine triphos-ignal
ortico
well.
N-ace
odineearby fibroblasts to produce extracellular matrix (6). We
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February 23, 2010:758–70 Mineralocorticoid Receptor and AFurther found that angiotensin II increased the expression of
R in cardiac fibroblasts, which might augment the response
f cardiac fibroblasts to aldosterone stimulation (data not
hown and provided upon request). However, we found that
ldosterone itself did not increase the expression of pro-
ollagens, such as pro-collagen type 1 alpha 1 (COL1A1),
ype 2 alpha 1 (COL2A1), and type 3 alpha 1 (COL3A1),
n cardiac fibroblasts (data not shown). Whether aldoste-
one stimulates collagen synthesis still remains controversial
22–25). Some studies showed a positive result (22,23), but
thers did not (24,25). Therefore, the role of aldosterone in
trial structural remodeling needs further studies.
Nevertheless, structural and electrical remodelings usually
oexist. Rapid depolarization is present in all kinds of AF
odels and in all patients with AF. The result of the cellular
tudy may imply that MR expression is up-regulated when
apid depolarization is present, irrespective of the presence
r absence of structural remodeling.
tudy limitations. First, most of the atrial tissue was ob-
ained from patients suffering from significant valvular heart
isease and left atrial enlargement. Although we also included
he second study group with less left atrial enlargement, these
atients did not have pure lone AF. Therefore, the results of
he first part of the study cannot be extrapolated in AF patients
ith other underlying conditions, especially those with lone
F. Second, only right atrial samples were obtained in the first
art of the study. We could not exclude the regional differences
n the measured parameters. For example, the left atrium has
ower metabolic reserve and increased wall stress compared
ith the right atrium, especially in patients with valvular
bnormalities of the left heart. Finally, we did not find any
ifference of atrial aldosterone levels between the study groups.
he atrial aldosterone might come from the systemic circula-
ion. Use of diuretics is known to activate RAS and increase
lasma aldosterone level (26). Therefore, a potential difference
f atrial aldosterone level might be obscured due to use of
iuretics, because most of the study subjects, either those with
F or those with NSR, were receiving diuretics.
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APPENDIX
or an expanded Methods section and supplementary figures, please seehomeostasis in human aortic smooth muscle cells (HAoSMCs) induced by
aldosterone. Pflugers Arch 2007;454:403–13. the Online Appendix.
